NUR-641E Advanced Pathophysiology and Pharmacology for the Nurse Educator with complete solution latest 2021 100% Verified.
Pharmacokinetics ✔✔ Involves ADME (absorption, distribution, metabolism and elimination).
...
NUR-641E Advanced Pathophysiology and Pharmacology for the Nurse Educator with complete solution latest 2021 100% Verified.
Pharmacokinetics ✔✔ Involves ADME (absorption, distribution, metabolism and elimination).
Absorption: absorption from the administration site either directly or indirectly into the blood/plasma.
Distribution: reversibly or irreversibly move from the bloodstream into the interstitial and intracellular fluid.
Metabolism: bio-transformed via hepatic metabolism or by other tissues.
Elimination: lastly, the drug & its metabolites are eliminated from the body
The route of administration with the highest bio-availability is ✔✔ Intravenous; putting entire dose into a patient's vein and bypassing absorption. Intravenous route avoids first-pass metabolism in the liver.
rectal administration disadvantages ✔✔ variable and erratic absorption
Steady state (SS) ✔✔ is usually reached within 4-5 half-lives of a drug
The half-life of a drug is defined as ✔✔ how long it takes for half the drug to be excreted from the body
Half-life of a drug ✔✔ Determines how frequently the drug must be administered
Predicts how long toxic effects can last
Half-life is constant with first-order pharmacokinetics of a drug
Zero-order (nonlinear) pharmacokinetics means a drug is metabolized at a constant rate per unit time.
CYP3A4 substrate drugs ✔✔ May have enhanced activity if any CYP3A4 inducer drugs are used along with it.
Drug development steps (according to the FDA) ✔✔ Discovery: laboratory research to develop the new drug
Pre-clinical research with animal testing for safety (Phase I)
Clinical research on human subjects for medication safety (Phase II)
Clinical research in humans comparing the new drug to accepted medications or placebo depending on the study (Phase III)
FDA review of the results to determine approval
Post-marketing study to identify adverse effects not found in earlier clinical studies (Phase IV)
[Show More]